225 related articles for article (PubMed ID: 30079976)
1. Identification of α-Mangostin as an Agonist of Human STING.
Zhang Y; Sun Z; Pei J; Luo Q; Zeng X; Li Q; Yang Z; Quan J
ChemMedChem; 2018 Oct; 13(19):2057-2064. PubMed ID: 30079976
[TBL] [Abstract][Full Text] [Related]
2. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.
Conlon J; Burdette DL; Sharma S; Bhat N; Thompson M; Jiang Z; Rathinam VA; Monks B; Jin T; Xiao TS; Vogel SN; Vance RE; Fitzgerald KA
J Immunol; 2013 May; 190(10):5216-25. PubMed ID: 23585680
[TBL] [Abstract][Full Text] [Related]
3. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
Downey CM; Aghaei M; Schwendener RA; Jirik FR
PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
[TBL] [Abstract][Full Text] [Related]
4. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.
Prantner D; Perkins DJ; Lai W; Williams MS; Sharma S; Fitzgerald KA; Vogel SN
J Biol Chem; 2012 Nov; 287(47):39776-88. PubMed ID: 23027866
[TBL] [Abstract][Full Text] [Related]
5. Discovery of triazoloquinoxaline as novel STING agonists via structure-based virtual screening.
Hou H; Yang R; Liu X; Wu X; Zhang S; Chen K; Zheng M
Bioorg Chem; 2020 Jul; 100():103958. PubMed ID: 32470762
[TBL] [Abstract][Full Text] [Related]
6. Integrative Strategy for Investigating the Interactions between STING and Small-Molecule Ligands.
Xu Y; Li W; Zhou X; Gao Y; Ding L; Xu L; Mao X; Zhou A; Wang X; Ning X
Langmuir; 2022 Nov; 38(46):14185-14191. PubMed ID: 36354159
[TBL] [Abstract][Full Text] [Related]
7. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models.
Jing W; McAllister D; Vonderhaar EP; Palen K; Riese MJ; Gershan J; Johnson BD; Dwinell MB
J Immunother Cancer; 2019 Apr; 7(1):115. PubMed ID: 31036082
[TBL] [Abstract][Full Text] [Related]
8. Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome.
Papinska J; Bagavant H; Gmyrek GB; Sroka M; Tummala S; Fitzgerald KA; Deshmukh US
J Dent Res; 2018 Jul; 97(8):893-900. PubMed ID: 29505322
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
Roberts ZJ; Goutagny N; Perera PY; Kato H; Kumar H; Kawai T; Akira S; Savan R; van Echo D; Fitzgerald KA; Young HA; Ching LM; Vogel SN
J Exp Med; 2007 Jul; 204(7):1559-69. PubMed ID: 17562815
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA.
Gao P; Ascano M; Zillinger T; Wang W; Dai P; Serganov AA; Gaffney BL; Shuman S; Jones RA; Deng L; Hartmann G; Barchet W; Tuschl T; Patel DJ
Cell; 2013 Aug; 154(4):748-62. PubMed ID: 23910378
[TBL] [Abstract][Full Text] [Related]
11. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation.
Xiao Z; Cui X; Liu F; Wang Y; Liu X; Zhou W; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167149. PubMed ID: 38565383
[TBL] [Abstract][Full Text] [Related]
12. TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.
Li Y; James SJ; Wyllie DH; Wynne C; Czibula A; Bukhari A; Pye K; Bte Mustafah SM; Fajka-Boja R; Szabo E; Angyal A; Hegedus Z; Kovacs L; Hill AVS; Jefferies CA; Wilson HL; Yongliang Z; Kiss-Toth E
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16479-16488. PubMed ID: 31346090
[TBL] [Abstract][Full Text] [Related]
13. The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease.
Cerón S; North BJ; Taylor SA; Leib DA
Virology; 2019 Mar; 529():23-28. PubMed ID: 30648635
[TBL] [Abstract][Full Text] [Related]
14. Rat and human STINGs profile similarly towards anticancer/antiviral compounds.
Zhang H; Han MJ; Tao J; Ye ZY; Du XX; Deng MJ; Zhang XY; Li LF; Jiang ZF; Su XD
Sci Rep; 2015 Dec; 5():18035. PubMed ID: 26669264
[TBL] [Abstract][Full Text] [Related]
15. STING agonists induce an innate antiviral immune response against hepatitis B virus.
Guo F; Han Y; Zhao X; Wang J; Liu F; Xu C; Wei L; Jiang JD; Block TM; Guo JT; Chang J
Antimicrob Agents Chemother; 2015 Feb; 59(2):1273-81. PubMed ID: 25512416
[TBL] [Abstract][Full Text] [Related]
16. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.
Temizoz B; Shibahara T; Hioki K; Hayashi T; Kobiyama K; Lee MSJ; Surucu N; Sag E; Kumanogoh A; Yamamoto M; Gursel M; Ozen S; Kuroda E; Coban C; Ishii KJ
Front Immunol; 2024; 15():1353336. PubMed ID: 38533502
[TBL] [Abstract][Full Text] [Related]
17. Anticancer flavonoids are mouse-selective STING agonists.
Kim S; Li L; Maliga Z; Yin Q; Wu H; Mitchison TJ
ACS Chem Biol; 2013 Jul; 8(7):1396-401. PubMed ID: 23683494
[TBL] [Abstract][Full Text] [Related]
18. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.
Zhang X; Liu B; Tang L; Su Q; Hwang N; Sehgal M; Cheng J; Ma J; Zhang X; Tan Y; Zhou Y; Duan Z; DeFilippis VR; Viswanathan U; Kulp J; Du Y; Guo JT; Chang J
ACS Infect Dis; 2019 Jul; 5(7):1139-1149. PubMed ID: 31060350
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA.
Chang J; Hou S; Yan X; Li W; Xiao J
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
